Pathophysiology of Sickle Cell Anemia in India for Nigerian Patients

Get a clear overview of sickle cell anemia pathophysiology from Indian specialists for Nigerian patients. GetWellGo explains how the disease develops.

Pathophysiology of Sickle Cell Anemia in India for Nigerian Patients

  • Category

    General

  • Published By

    GetWellGo Team

  • Updated on

    29-Jan-2026

Pathophysiology of sickle cell anemia in India for Nigerian Patients

Sickle Cell Anemia is a genetic blood disease relating to the structure and function of the red blood cells (RBCs). It is common in some parts of West Africa, like Nigeria, and a number of patients routinely travel to India for complex diagnosis and treatment as hematology and transplant care is affordable and world class. 

Genetic Cause

  • The cause of sickle cell anemia is a gene mutation that each parent must pass on for their child to develop the disease.
  • The mutant gene produces a defective form of hemoglobin called Hemoglobin S (HbS) compared to the normal Hemoglobin A (HbA).
  • Normal hemoglobin - makes it easy for the body to transport oxygen.
  • O2 levels drop, HbS polymerizes – becomes sticky and rigid. 

Red Blood Cell Shape Change

Under low oxygen conditions (such as in infection, dehydration, or stress) HbS causes red blood cells to: 

  • Transformation of a round and flexible form.
  • And into a crescent or a sickle shape.

These sickled cells:

  • Which should not flow through blood vessels easily
  • Lyses up excessively rapidly RBCs.

Chronic Anemia Development

  • Normal RBCs live for about 120 days, and sick cells live for about 10-20 days. 

This leads to:

  • Recurrent deficiency of red blood cells.
  • Limited supply of oxygen to the body organs.
  • Like fatigue, shortness of breath, and slowed growth in children.

Blockage of the blood vessels (vaso-occlusion)

  • It is also possible for the sickled cells to stick to the blood vessel walls and cause blockages. 

This results in:

  • Extreme episodes of pain (referred to as pain crisis)
  • Organ damage over time
  • Risk of stroke, chest infections, renal failure and bone disease.

Enhanced infection risk 

  • The sickle cell disease destroys the spleen which is used to combat infections.

Therefore, patients are at greater risk of:

  • Bacterial infections
  • Malaria (of special importance in the case of Nigerian individuals)
  • Pneumonia and sepsis - the usual suspects

Organ damage and hypoxia 

The organization of blood supply results in inadequate oxygen supply (ischemia) of the essential organs like:

  • Brain → stroke risk
  • Lungs → Acute Chest Syndrome
  • Kidneys → Chronic Kidney Disease.
  • Bone avascular necrosis and joint destruction → Osteonecrosis of bones and joint damage. 

The reason behind Indian Hospitals on Advanced Monitoring

In the case of Nigerian patients who get treatment in India, physicians closely observe:

  • Hemoglobin levels
  • Blood oxygen levels
  • Organs of the system (heart, kidneys, brain) 
  • Infection markers

This will assist in avoiding complication and leading to treatments such as:

  • Hydroxyurea treatment
  • Blood transfusion
  • Stem cell or marrow transplant (potential cure for some patients)

Pathophysiology of sickle cell anemia

Sickle Cell Disease is a hereditary disorder resulting from a mutation in the β-globin gene of the hemoglobin (referred to as the HBB gene) which gives rise to an abnormal form of the protein designated as hemoglobin S (HbS).The pathophysiology of this disease is a cascade of related events: 

Genetic Mutation and the Structure of Hemoglobin

  • Origin: Single base pair mutation in the β-globin gene on chromosome 11.
  • Result: A glutamic acid was replaced with a valine at the 6th amino acid position in the β-globin chain.
  • Effect: They produce sickle hemoglobin and not the regular adult haemoglobin.

Polymerization of Hemoglobin S 

  • At low oxygen (hypoxic) tension HbS polymerizes (gels) and forms long, rigid rods.
  • This causes red blood cells (RBCs) to take on a sickled or crescent shape. 

Red Blood Cell Sickling

Sickled RBCs are:

  • Hard and less flexible
  • Susceptible to hemolysis (breaking up prematurely)
  • Have a shorter life span (~10–20 days compared to 120 days for healthy RBCs)

Vaso-occlusion

Sickled cells:

  • Become trapped in small capillaries
  • Induce obstructions (vaso-occlusion) in blood vessels
  • Lead to tissue ischemia, pain (sickle cell crises), and organ injury

Hemolysis and Anaemia

Progressive destruction of sickle cells results in:

  • Hemolytic anemia (depleted hemoglobin) levels
  • Hyperbilirubinemia (resulting from RBC destruction)
  • Gallstones (because of increased bilirubin)

Inflammation and Endothelial Dysfunction

Vaso-occlusion and ischemia lead to:

  • Inflammatory cytokines
  • Endothelial activation and damage
  • More adhesion of leukocytes and sickled cells to blood vessel walls

Sickle cell anemia pathophysiology India Nigerians

Sickle Cell Anemia is a genetic blood condition that causes red blood cells to become abnormally shaped, leading to the formation of chronic anemia, pain crises, infections, and organ damage. It holds in parts of Nigeria and sub-Saharan Africa and that many patients travel to India for high quality hematology and transplant care at a fraction of the cost. 

Why Indian patients have so many Nigerian patients?

The hospitals in India have the following to offer:

  • Advanced blood tests and genetic analysis.
  • Regular transfusion procedures.
  • Hydroxyurea treatments
  • Bone marrow/stem cell transplants. 
  • Specialized international patient care.

Sickle cell anemia complications Nigerian treatment India

Sickle Cell Anemia is an incurable hereditary condition of the blood that is likely to cause severe complications otherwise. Nigerian patients also go to India in large numbers to receive improved and affordable care that includes long-term medical care and curative transplant procedures.

Major Complications of Sickle Cell Anemia:

  • Pain Crises
  • Severe Infections
  • Stroke
  • Acute Chest Syndrome
  • Chronic Anemia & Fatigue
  • Kidney Damage
  • Bone & Joint Problems
  • Vision Problems
  • Delayed Growth & Puberty

Indian treatment options of the Nigerian patients

Medical Management:

Hydroxyurea Therapy

  • Enhances fetal hemoglobin (HbF).
  • Minimizes crises of pain and hospitalization.

Blood Transfusions

  • Means of treating serious anemia and stroke prevention.
  • Exchange transfers in major Indian capitals.

Vaccines and antibiotics

  • Prevent a severe infection 
  • Of particular significance in children.

Developed and Palliative Therapies:

Bone marrow/ Stem Cell Transplant

  • Only proven cure
  • Optimal success in children that are matched siblings.
  • In India transplant centers with specialization.

Gene Therapy (Limited Centers)

  • New treatment in the chosen hospitals.
  • Expensive and scarce.

Supportive Care:

  • Pain management programs
  • Oxygen therapy
  • Nutritional support
  • Psychological counselling
  • Guidelines on malaria prevention.

Sickle cell endothelial damage pathophysiology India

One of the main pathways of sickle cell disease complications is endothelial damage, which leads to vaso-occlusion, inflammation, thrombosis, and organ injury. The knowledge of this process can inform the development of advanced therapy interventions applied in the Indian hematology and transplant centers.

What is the Endothelium?

Endothelium is a term for the single cell layer forming the lining which lies at the interior surface of blood vessels. It:

  • Regulates blood flow
  • Prevents clotting
  • Controls inflammation
  • Releases nitric oxide (NO) to maintain vessels in state of relaxation.
  • This protective layer gets activated and destroyed in sickle cell disease.

Causative agent: Hemoglobin S and Hemolysis

Sickling & Hemolysis

  • HbS polymerizes in the absence of oxygen and makes red blood cells (RBCs) sickle.

Sickled RBCs lyse (hemolysis), releasing:

  • Free hemoglobin
  • Heme
  • Red cell fragments (microparticles)
  • These are toxic agents to endothelial cells.

Depletion of Nitric Oxide

  • Free hemoglobin binds and scavenges nitric oxide (NO). 

Reduced NO causes:

  • Narrowing of blood vessels
  • Heightened platelet activation.
  • Increased vulnerability of clot development.
  • This forms a low flow, high adhesion environment.

Endothelial Activation

Endothelial cells react by producing adhesion molecules such as: 

  • VCAM-1
  • ICAM-1
  • P-selectin
  • E-selectin

This act like “hooks” that:

  • Trap sickled RBCs
  • Seize platelets and white blood cells.
  • Encourage blockage of the vessels (vaso-occlusion).

Inflammation Cascade

Dysfunctional endothelium secretes:

  • Cytokines 
  • Reactive oxygen species 

This leads to:

  • Chronic inflammation
  • Enhanced vascular permeability.
  • Further endothelial injury

Hypercoagulability

Endothelial dysfunction favours: 

  • Tissue factor expression
  • Platelet activation
  • Reduction in natural anticoagulants

This creates a pro-thrombotic clotting and leads to: 

  • Stroke
  • Pulmonary hypertension
  • Organ infarction

Sickle cell anemia genetics Nigeria patients India

Sickle Cell Anemia is a genetic blood disease resulting from a mutation (alteration) in the gene that produces hemoglobin, a protein that transports oxygen in the red blood cells. It is endemic in Nigeria and to an extent in parts of sub-Saharan Africa, and a few patients are visiting India for advanced genetic tests, counselling and even curative therapy. 

The Gene Involved

  • The disorder results from a mutation in the β-globin gene. 
  • Location: Chromosome 11
  • This gene is the sources of a large part of Hemoglobin A (HbA). 

The Mutation

  • Normal codon of DNA: GAG changes to glutamic acid.
  • Altered codon: GTG to forms valine.
  • This single mutation produces Hemoglobin S (HbS) rather than HbA.

Autosomal Recessive Pattern of Inheritance

  • A child must inherit two sickle genes (one from each parent) to have sickle cell anemia.

Sickle Cell Trait among Nigerian Population

  • Common in Nigeria wiith some historical protection against Malaria. 
  • Carriers tend to lead ordinary lives.
  • Can pass the gene to children
  • There is a strong recommendation of genetic counselling prior to marriage or pregnancy.

Genetic Testing in India for Nigerian Patients

Indian hospitals provide advanced testing like:

  • Hemoglobin electrophoresis
  • High performance liquid chromatography (HPLC) testing
  • DNA mutation analysis
  • Prenatal testing 
  • Preimplantation genetic testing for patients undergoing IVF 

The Role of Genetics in Making Treatment Decisions

Doctors use genetic findings to determine:

  • Prognosis of disease severity
  • Transplant suitability
  • Donor selection for bone marrow or stem cell transplantation
  • Family screening and counselling

Option for Cure – Genetic Match Transplant

  • Best cure: Matched sibling bone marrow or stem cell transplant
  • Indian HLA genetic typing centers utilize the HLA genetic typing to identify a potential donor
  • Better success in pediatrics and young adults

Conclusion

Sickle cell anemia is a genetically transmitted blood disease resulting from a point mutation in the β­globin gene, which leads to the production of abnormal hemoglobin S. These changes in blood cells lead to chronic anemia, painful vaso-occlusive crises, areplenia contributing to increased risk of infection, and cumulative injury to brain end-organ, lung, kidney, and skeleton. Early genetic screening and counselling is therefore crucial in Nigeria, where the sickle cell trait and disease is endemic for prevention and family planning. Indian medical institutions offer holistic management for Nigerian clients through comprehensive diagnostic evaluation, standard therapy such as hydroxyurea for disease modification, organized transfusion therapy for management of endothelial and inflammatory complications and curative modalities like bone marrow and stem cell transplantation to enhance survival, quality of life and long-term prognosis.

Sickle cell pathophysiology India GetWellGo Nigerians

GetWellGo is regarded as a leading supplier of healthcare services. We help Nigerian patients choose the best treatment locations that suit their needs both financially and medically.

We offer:

  • Complete transparency
  • Fair costs.
  • 24 hour availability.
  • Medical E-visas
  • Online consultation from recognized Indian experts.
  • Assistance in selecting India's top hospitals for sickle cell anemia treatment.
  • Expert doctors with a strong track record of success
  • Assistance during and after the course of treatment.
  • Language Support
  • Travel and Accommodation Services
  • Case manager assigned to every patient to provide seamless support in and out of the hospital like appointment booking
  • Local SIM Cards
  • Currency Exchange
  • Arranging Patient’s local food







 

Recent Blogs